Navigation Links
Jivan Focuses on Solutions for Transcriptome Sequencing
Date:4/9/2009

LARKSPUR, Calif., April 9 /PRNewswire/ -- Jivan announced today that it will provide bioinformatics solutions for high-throughput transcriptome sequencing (RNA-Seq) and expression. Leveraging Jivan's industry-leading bioinformatics infrastructure for analysis of mRNA in biological samples, Jivan will provide "bioinformatics for the next generation." Jivan will offer content for targeted sequencing with mRNA capture arrays, mRNA specific PCR primer designs for targeted amplification, and software for analyzing mRNA expression from RNA-Seq, multiplexed PCR and microarrays.

"Jivan is uniquely situated to address the informatics challenges of transcriptome sequencing," said Subha Srinivasan, PhD, CEO of Jivan. "Our mRNA sequence databases, software infrastructure, oligonucleotide design capabilities, and expression analysis software give us a tremendous advantage in developing solutions for RNA sequencing."

Jivan has developed a database for analysis of mRNA expression from transcriptome sequencing. It enables advanced expression counts that go beyond the basic reads per kilo base (rpkb) that is the current standard.

To support RNA sequencing, Jivan's technology offering will include mRNA Capture Arrays for targeted sequencing of genomes, gene families and therapeutic areas. By using Jivan's database of mRNA sequences, including exons and exon junctions, Jivan can ensure the capture of all mRNA sequences of each gene of interest, including wildtype transcripts and splice variants. For genes or mRNAs with low expression, Jivan will offer mRNA Prime(TM) PCR primer designs specific to each observed mRNA.

To analyze RNA sequencing data, Jivan will offer a software tool called mRNA Magic(TM) that provides functionality for sophisticated expression analysis from sequence reads.

For more information, see http://www.jivanbio.com.

About Jivan

Jivan empowers scientists with new insight by providing a full range of products and services for mRNA sequencing and expression, including capture arrays, PCR primers and amplicons, and transcriptome sequencing software.

    Contact:

    Jonathan Bingham
    jbingham@jivanbio.com
    +1 415 425 4115

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Jivan Biologics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Jivan Awarded US Patent #7,340,349 for Splice Array Analysis
2. International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development
3. GPhA Annual Meeting Focuses on Industry Opportunities and Challenges for 2008
4. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
5. Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells
6. New Initiative Focuses on Water Quality Improvement in the Mississippi River Basin and Gulf of Mexico
7. ECBCs Environmental BioMonitoring Laboratory Focuses on the Future
8. Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinsons Disease
9. Siemens Focuses on Role-Based, Context-Sensitive, and Knowledge-Driven Solutions at HIMSS 2009
10. ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... One Million Solutions in Health ... million in investment towards 15+ TEC Validation Projects™. As a pre-competitive consortium, ... in drug safety assessment, for the industry as a whole. , Through the ...
(Date:1/16/2017)... ... January 16, 2017 , ... Appellate Court of New ... the appeal filed by India-based Dishman Pharmaceutical & Chemical Ltd. company (DPCL) for ... one of its Dishman Group’s 100% wholly owned New Jersey-based subsidiary Dishman USA ...
(Date:1/14/2017)... -- The Alliance for Safe Biologic Medicines (ASBM) today issued ... guidance on biologic naming: We commend ... importance of distinct naming for all biologics, including biosimilars. ... will bring to patients, including new treatment options and ... the Guidance dealing with suffix design remains at odds ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... teamed up with several companies to offer its customers three new solutions for ... probe would come in handy if a customer has an oddly-shaped sample that ...
Breaking Biology Technology:
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical device ... billion by 2021 from USD 5.31 billion in 2016, at a ... ... driven by technological advancements in medical devices, launch of a growing ... for wireless connectivity among healthcare providers, and increasing focus on physical ...
(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... Dec. 15, 2016 Advancements in ... health wellness and wellbeing (HWW), and security ... three new passenger vehicles begin to feature ... recognition, heart beat monitoring, brain wave monitoring, ... monitoring, and pulse detection. These will be ...
Breaking Biology News(10 mins):